DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for carpal tunnel syndrome 1 — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleCarpal tunnel syndrome 1 maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for carpal tunnel syndrome 1 is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
transthyretin (TTR) — TTR is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet 2,4-dimethylphenyldrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 8C86 · 1.1 Å · ligand (2,4-dimethylphenyl)(4-hydroxy-3-methoxy-5-nitrophenyl)methanone (TQ0). Experimental structure, not a prediction.
What the evidence adds up to
Carpal tunnel syndrome is a common entrapment neuropathy caused by compression of the median nerve at the wrist, and an integrated review from 2023 notes that congenital anatomical factors, such as a smaller carpal tunnel, and genetic variants in genes for extracellular matrix remodelling, inflammation, and nerve function have been linked to increased risk. The same review states that the condition is associated with high healthcare costs and loss of work productivity, and that biological, genetic, environmental, and occupational factors interact with structural elements to determine who is most likely to develop it. A 2024 study of 345 carpal tunnel syndrome patients and 1035 healthy controls in a Polish population genotyped variants in the COL11A, COL1A, COL5A1, COMP, and GSTM1 genes and found no independent association between any of the examined variants and the condition; four uncertain variants were identified but appear extremely rare in that population.
A 2013 letter commenting on a randomised placebo-controlled trial reports that local methylprednisolone injections produced only temporary relief of carpal tunnel syndrome. After week 36, the number of patients who had surgery increased, reaching between 73% and 81% by the end of the first year. Secondary endpoints, including the short Disabilities of the Arm, Shoulder and Hand score, Short Form-36 bodily pain score, and Short Form-6D score, as well as treatment satisfaction, showed no differences between methylprednisolone and placebo after 10 weeks. A 2006 review of outcomes research notes that although surgery for carpal tunnel syndrome is commonly performed, the outcomes of these surgical procedures remain relatively unclear based on the best available evidence.
A 2018 study examined 42 people with diagnosed carpal tunnel syndrome and found that in complex treatment, alongside standard therapy with alpha-lipoic acid and pentoxifylline, there were effective mobilisation and traction techniques of the wrist and elbow joint, as well as post-isometric relaxation of several shoulder muscles. The study does not provide response rates, survival data, or comparative outcomes against standard therapy alone.
What is still missing are large, adequately powered trials that stratify patients by genetic, anatomical, or electrodiagnostic severity, and that compare surgical outcomes against placebo or sham surgery with long-term follow-up. Funding for such trials, and for replication of the genetic association study in larger and more diverse populations, remains absent.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Cureus · 2023 · 33 citations · open access
An Integrated Review of Carpal Tunnel Syndrome: New Insights to an Old Problem
AbstractCarpal tunnel syndrome (CTS) is a common entrapment neuropathy characterized by pain, numbness, and impaired function of the hand due to compression of the median nerve at the level of the wrist. Although CTS can develop from repetitive strain, injury, or medical conditions, there are also congenital and genetic risk factors that can predispose individuals to the condition. With respect to anatomical factors, some individuals are born with a smaller carpal tunnel, which increases their susceptibility to median nerve compression. Variations in specific genes, such as those encoding proteins involved in extracellular matrix remodeling, inflammation, and nerve function, have also been linked to an increased risk for CTS. CTS is associated with a high cost of health care maintenance and loss of work productivity. Therefore, it is vital that primary care physicians fully understand the anatomy, epidemiology, pathophysiology, etiology, and risk factors of CTS, so they can be proactive in prevention, diagnosing, and guiding proper treatment. This integrated review also provides insights into how biological, genetic, environmental, and occupational factors interact with structural elements to determine who is most likely to acquire and suffer from CTS. Keeping health practitioners abreast of all the factors that could impact CTS should go a long way in decreasing the health care and socioeconomic burden of CTS.
Current Status of Outcomes Research in Carpal Tunnel Surgery
AbstractMore than 3,000 publications on carpal tunnel syndrome (CTS) have been presented in the literature. Although surgery for treating CTS is commonly performed, the outcomes of these surgical procedures are still relatively unclear. This paper will summarize relevant publications on the surgical treatment of CTS to critically examine outcomes data based on the best available evidence.
Electronic physician · 2016 · 8 citations · open access
Does Hypothyroidism Affect Post-Operative Outcome of Patients Undergoing Carpal Tunnel Release?
AbstractINTRODUCTION: Risk factors associated with Carpal Tunnel Syndrome include repetitive use of hand and wrist, advanced age, obesity, pregnancy, diabetes mellitus and thyroid disease. Decompression of the median nerve is the last treatment of choice usually indicated when negative results to conservative treatments remain for three months. In this study, we aimed to find out whether hypothyroid patients would respond to CTS surgical decompression differently in comparison to healthy individuals. METHODS: This case control study was conducted on patients with CTS in need of surgical release who were refered to Shahid Faghihi hospital, International Branch of Shiraz University of Medical Sciences, Shiraz, Iran from January 2013 to January 2015. Twenty-five hypothyroid and 22 euthyroid patients were recruited. Hypothyroidism was diagnosed based on clinical symptoms and serum TSH level. All patients were followed for three weeks after surgery and a Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) was completed for them pre and post operation. An electrophysiological study was performed during the same follow up period. Statistical analysis was performed using SPSS version 16. RESULTS: The CTS grade reported by electrophysiological study, decreased significantly 3 weeks after operation in comparison with preoperative grades (p<0.001). A significant decrease was observed in the immediate postoperative BCTQ scores compared to preoperative (p<0.001). Also a decrease was detected in the three weeks of postoperative follow up compared to immediate postoperative BCTQ scores (p<0.001) and preoperative BCTQ scores (p<0.001). Postoperative BCTQ scores of euthyroid patients decreased more in comparison to hypothyroid patients (p<0.001). CONCLUSION: It seems that, hypothyroidism has an effect on postoperative outcome of carpal tunnel release.
Inherited Variants in the COL11A, COL1A, COL5A1, COMP, GSTM1 Genes and the Risk of Carpal Tunnel Syndrome
AbstractThe pathogenesis of most cases of carpal tunnel syndrome is not clearly defined. There are some aspects of the disease that suggest a potential effect of genetic predispositions. Mutations (variants) within the genes encoding various subtypes of collagen synthesis, oligomerisation in the endoplasmic reticulum and inactivation of reactive oxygen species may be involved in the development of carpal tunnel syndrome. The objective of this study was to determine the role of DNA alterations within the COL11A, COL1A, COL5A1, COMP and GSTM1 genes in the pathogenesis of carpal tunnel syndrome based on a Polish population. STUDY DESIGN: In the discovery phase, a total of 96 patients with familial aggregation of CTS were genotyped using a Next Generation Sequencing panel in order to find possible mutations within the studied genes. The potential pathogenicity of the detected variants was investigated using the predictions of several in-silico algorithms and the TaqMan technology. In the association phase of the study, a group of 345 CTS patients and 1035 healthy controls were genotyped. RESULTS: A total of 35 splice-site or exonic non-synonymous variants were detected by NGS. We did not identify any clearly pathogenic or likely pathogenic alternations. The 30 variants were identified as benign or likely benign. Five missense changes were predicted as VUS and selected for association study. The COL5A1 c.1595 C>T (p.Ala532Val) was detected in one out of 345 cases and three out of 1035 controls (P=1, OR=1); this indicates that the variant is a neutral alteration. Four remaining variants - c.2840 C>A, c.5395 G>A, c.1331 C>G, c.1590 C>A - were present in none out of the 345 CTS patients and none out of 1035 controls. CONCLUSION: The main finding of this study was that there was no independent association between the variants of five examined genes and carpal tunnel syndrome. Four uncertain variants were identified that seem to be extremely rare in the Polish population.
Complex approach to treatment of the carpal tunnel syndrome, with the use of methods of manual therapy
Abstract42 people with diagnosed carpal tunnel syndrome were examined. It was found that in the complex treatment of carpal tunnel syndrome, along with standard therapy in the form of preparations of alpha-lipoic acid and pentoxyfylline, there are effective mobilization and traction techniques of the wrist, elbow joint, as well as post-isometric relaxation of m. deltoideus, m. infraspinatus, m. supraspinatus, m. minor and major teres, m. subscapularis, m. pectoralis minor.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
